4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002479
Chief Discovery/Trans Medicine sold 13,803 shares at $37.40 ($516,232)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamilton James C Chief Discovery/Trans Medicine | 2023-01-05 | Sale | −7,230 | $37.40 | $270,402 | 198,057 | D |
| Hamilton James C Chief Discovery/Trans Medicine | 2023-01-05 | Sale | −6,573 | $37.40 | $245,830 | 191,484 | D |
| Open-market sales · 13,803 sh · avg $37.40 · $516,232 | |||||||
Loading xslF345X03/doc4.xml…